Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

Filter by
  • Filter by
  • Remove this filter Infectious disease: Meningococcal disease
  • Infectious disease
    • Meningococcal disease (66)
    • Vaccine preventable diseases (66)
    • Invasive meningococcal disease (66)
    • Respiratory diseases (17)
    • Invasive Haemophilus influenzae disease (13)
    • Haemophilus infection (13)
    • Haemophilus influenzae type b (HiB) infection (13)
    • Poliomyelitis (12)
    • Influenza (12)
    • Food- and waterborne diseases (11)
    • Mosquito-borne diseases (10)
    • Pneumococcal disease (10)
    • Invasive pneumococcal disease (10)
    • Streptococcus pneumoniae (10)
    • S. pneumoniae (10)
    • Rubella (8)
    • Tuberculosis (8)
    • Viral haemorrhagic fever (8)
    • West Nile virus infection (8)
    • Viral hepatitis (8)
    • Hepatitis A (8)
    • German measles (8)
    • Measles (8)
    • Zoonosis (7)
    • Diphtheria (7)
    • Chikungunya virus disease (7)
    • Severe acute respiratory syndrome (SARS) (7)
    • Ebola haemorrhagic fever (7)
    • Sexually transmitted infections (6)
    • Hepatitis B (6)
    • Mumps (6)
    • Middle East respiratory syndrome coronavirus (5)
    • Pertussis (5)
    • Salmonellosis (5)
    • Tick-borne diseases (5)
    • Dengue (5)
    • Rabies (5)
    • Smallpox (5)
    • Yellow fever (5)
    • Marburg haemorrhagic fever (5)
    • Whooping cough (5)
    • Marburg virus diseases (5)
    • Anthrax (5)
    • Lassa fever (5)
    • Cryptosporidiosis (4)
    • Malaria (4)
    • Healthcare-associated infections (4)
    • Giardiasis (4)
    • Cholera (4)
    • Echinococcosis (4)
    • Rift Valley fever (4)
    • Leptospirosis (4)
    • Q fever (4)
    • Plague (4)
    • Shigellosis (4)
    • Botulism (4)
    • Listeriosis (4)
    • Hepatitis C (4)
    • Crimean-Congo haemorrhagic fever (4)
    • Campylobacteriosis (4)
    • Acquired immunodeficiency syndrome (AIDS) (4)
    • Human immunodeficiency virus infection (4)
    • Nephropathia epidemica (4)
    • Haemorrhagic fever with renal syndrome (Puumala caused) (4)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (4)
    • Shiga toxin producing Escherichia coli (STEC) infection (4)
    • Hantavirus infection (4)
    • Hydatidosis (4)
    • Nosocomial infections (4)
    • Escherichia coli infection (4)
    • Chlamydia infection (4)
    • HIV infection (4)
    • Verotoxigenic Escherichia coli infection (4)
    • Surgical site infections (3)
    • Influenza in humans, seasonal (3)
    • Flu (3)
    • Hospital-acquired infections (3)
    • Seasonal influenza (3)
    • Tetanus (2)
    • Varicella (2)
    • Human papillomavirus infection (2)
    • Chickenpox (2)
    • Cutaneous warts (2)
    • Rotavirus infection (1)
    • Vector-borne disease (1)
    • Zika virus disease (1)
    • Enterovirus (1)
    • Haemorrhagic fever (1)
    • Coxsackievirus (1)
    • Gastrointestinal disease (1)
  • Public health area
    • Surveillance (20)
    • Immunisation (15)
    • Vaccination (15)
    • Active immunisation (15)
    • Public health threat (12)
    • Outbreak (12)
    • Threats and outbreaks (12)
    • Scientific advice (9)
    • Prophylaxis (4)
    • Disease prevention (4)
    • Mass gathering (4)
    • Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) (4)
    • Prevention and control (4)
    • Microbiology (4)
    • Travellers' health (3)
    • Infectious diseases on aircrafts (3)
    • Epidemiology (1)
    • Laboratory quality (1)
    • Preparedness (1)
    • Preventive measure (1)
    • Public health response (1)
    • Laboratories (1)
    • Control campaign (1)
  • Country
    • Europe (36)
    • Asia (3)
    • Africa (3)
    • Americas (2)
  • Media type
    • Publication (42)
    • Surveillance report (21)
    • Data (9)
    • Table (5)
    • Peer-reviewed publication (4)
    • Technical report (4)
    • External quality assessment (4)
    • Risk assessment (4)
    • External link (4)
    • Technical guidance (3)
    • Event (2)
    • Tool (2)
    • News (2)
    • ECDC comment (2)
    • Meeting report (2)
    • Systematic review (1)
    • Expert opinion (1)
    • Public health guidance (1)
    • Campaign (1)
    • Map (1)
    • Factsheet (1)
    • Networks and partnerships (1)
    • Corporate information (1)
  • Page 1 of 7 // 66 Results found
    • Sort by:

Data

Surveillance systems overview for 2018

Table - 24 Oct 2019

This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2018.

  • Anthrax
  • Botulism
  • Campylobacteriosis
  • Chikungunya virus disease
  • Chlamydia infection
  • Cholera
  • Crimean-Congo haemorrhagic fever
  • Cryptosporidiosis
  • Dengue
  • Diphtheria
  • Ebola haemorrhagic fever
  • Echinococcosis
  • EU/EEA
  • Giardiasis
  • Hantavirus infection
  • Healthcare-associated infections
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • HIV infection
  • Influenza
  • Invasive Haemophilus influenzae disease
  • Lassa fever
  • Leptospirosis
  • Listeriosis
  • Malaria
  • Marburg haemorrhagic fever
  • Meningococcal disease
  • Mumps
  • Pertussis
  • Plague
  • Pneumococcal disease
  • Poliomyelitis
  • Q fever
  • Rabies
  • Rift Valley fever
  • Salmonellosis
  • Severe acute respiratory syndrome (SARS)
  • Shigellosis
  • Smallpox
  • Surveillance
  • Verotoxigenic Escherichia coli infection
  • West Nile virus infection

Publication

Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019

Risk assessment - 2 Jul 2019

In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.

Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019 - EN - [PDF-1.13 MB]
  • Diphtheria
  • Food- and waterborne diseases
  • Hepatitis A
  • Hepatitis B
  • Influenza
  • Mass gathering
  • Measles
  • Meningococcal disease
  • Middle East respiratory syndrome coronavirus
  • Mumps
  • Poliomyelitis
  • Public health threat
  • Rabies
  • Rubella
  • Saudi Arabia
  • Tetanus
  • Travellers' health
  • Vaccine preventable diseases
  • Vector-borne disease

Publication

Invasive meningococcal disease - Annual Epidemiological Report for 2017

Surveillance report - 24 Apr 2019

In 2017, 3 221 confirmed cases of invasive meningococcal disease (IMD), including 282 deaths, were reported in 30 EU/EEA Member States.

Invasive meningococcal disease - Annual Epidemiological Report for 2017 - EN - [PDF-975.41 KB]
  • EU/EEA
  • Meningococcal disease
  • Surveillance

Data

Surveillance systems overview for 2017

Table - 7 Dec 2018

This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2017.

  • Anthrax
  • Botulism
  • Campylobacteriosis
  • Chikungunya virus disease
  • Chlamydia infection
  • Cholera
  • Crimean-Congo haemorrhagic fever
  • Cryptosporidiosis
  • Dengue
  • Diphtheria
  • Ebola haemorrhagic fever
  • Echinococcosis
  • EU/EEA
  • Giardiasis
  • Hantavirus infection
  • Healthcare-associated infections
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • HIV infection
  • Influenza
  • Invasive Haemophilus influenzae disease
  • Lassa fever
  • Leptospirosis
  • Listeriosis
  • Malaria
  • Marburg haemorrhagic fever
  • Meningococcal disease
  • Mumps
  • Pertussis
  • Plague
  • Pneumococcal disease
  • Poliomyelitis
  • Q fever
  • Rabies
  • Rift Valley fever
  • Salmonellosis
  • Severe acute respiratory syndrome (SARS)
  • Shigellosis
  • Smallpox
  • Surgical site infections
  • Surveillance
  • Tuberculosis
  • Verotoxigenic Escherichia coli infection
  • West Nile virus infection
  • Yellow fever

Publication

Invasive meningococcal disease - Annual Epidemiological Report for 2016

Surveillance report - 9 Aug 2018

In 2016, 3 280 confirmed cases of invasive meningococcal disease (IMD), including 304 deaths, were reported in 30 EU/EEA Member States.

Invasive meningococcal disease - Annual Epidemiological Report for 2016 - EN - [PDF-983.6 KB]
  • Meningococcal disease
  • Surveillance

Data

Surveillance systems overview for 2016

Table - 4 May 2018

This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2016.

  • Anthrax
  • Botulism
  • Campylobacteriosis
  • Chikungunya virus disease
  • Chlamydia infection
  • Cholera
  • Crimean-Congo haemorrhagic fever
  • Cryptosporidiosis
  • Dengue
  • Diphtheria
  • Ebola haemorrhagic fever
  • Echinococcosis
  • Giardiasis
  • Hantavirus infection
  • Healthcare-associated infections
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • HIV infection
  • Influenza
  • Invasive Haemophilus influenzae disease
  • Lassa fever
  • Leptospirosis
  • Listeriosis
  • Malaria
  • Marburg haemorrhagic fever
  • Meningococcal disease
  • Mumps
  • Pertussis
  • Plague
  • Pneumococcal disease
  • Poliomyelitis
  • Q fever
  • Rabies
  • Rift Valley fever
  • Salmonellosis
  • Severe acute respiratory syndrome (SARS)
  • Shigellosis
  • Smallpox
  • Surgical site infections
  • Surveillance
  • Tuberculosis
  • Verotoxigenic Escherichia coli infection
  • West Nile virus infection
  • Yellow fever

Publication

Communicable disease threats report, 4-10 February 2018, week 6

Publication - 9 Feb 2018

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 February 2018 and includes updates on poliomyelitis, hepatitis A, seasonal influenza, rubella, measles, meningitis, mass gathering monitoring (Olympics) and yellow fever.

Communicable Disease Threats Report, 10 February 2018 - EN - [PDF-493.38 KB]
  • Africa
  • Brazil
  • Denmark
  • EU/EEA
  • Hepatitis A
  • Influenza
  • Influenza in humans, seasonal
  • Mass gathering
  • Measles
  • Meningococcal disease
  • Poliomyelitis
  • Portugal
  • Public health threat
  • Rubella
  • South Korea
  • Yellow fever

Data

Surveillance systems overview for 2015

Table - 1 Jan 2018

This spreadsheet contains all surveillance system overview tables from the ECDC Annual Epidemiological Reports for 2015.

  • Anthrax
  • Botulism
  • Campylobacteriosis
  • Chikungunya virus disease
  • Chlamydia infection
  • Cholera
  • Crimean-Congo haemorrhagic fever
  • Cryptosporidiosis
  • Dengue
  • Diphtheria
  • Ebola haemorrhagic fever
  • Echinococcosis
  • Giardiasis
  • Hantavirus infection
  • Healthcare-associated infections
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • HIV infection
  • Influenza
  • Invasive Haemophilus influenzae disease
  • Lassa fever
  • Leptospirosis
  • Listeriosis
  • Malaria
  • Marburg haemorrhagic fever
  • Meningococcal disease
  • Mumps
  • Pertussis
  • Plague
  • Pneumococcal disease
  • Poliomyelitis
  • Q fever
  • Rabies
  • Rift Valley fever
  • Salmonellosis
  • Severe acute respiratory syndrome (SARS)
  • Shigellosis
  • Smallpox
  • Surgical site infections
  • Tuberculosis
  • Verotoxigenic Escherichia coli infection
  • West Nile virus infection
  • Yellow fever

Peer-Reviewed Publication

No consistent increased mortality risk for females compared to males in invasive meningococcal disease in the European Surveillance System (TESSy)

Jan 2018 - Clin. Infect. Dis. - Epub ahead of print

Naucler, P., Keramarou, M., Derrough, T.

  • Meningococcal disease
  • Surveillance

Publication

Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA

Expert opinion - 6 Dec 2017

This expert opinion is intended to support national decision-making by summarising the considerations and concerns of some EU/EEA countries when they discussed whether to introduce the 4CMenB vaccine into their national immunisation programmes.

Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA - EN - [PDF-1.66 MB]
  • EU/EEA
  • Immunisation
  • Meningococcal disease
  • Scientific advice

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2020
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us